Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-11, Stock:ABT, The news for the past five days is as follows:
2018-09-04: NEWS1: Fighting Opioids: Chronic Pain Device Gets Insurance Coverage.NEWS2: How Eli Lilly’s Elanco Performed in Q2 2018.NEWS3: New Coverage Decision Extends Abbott's Innovative Pain Therapy Option to 22 Million Americans Living with Chronic Pain.
2018-09-05: NEWS1: Analyzing Alexion Pharmaceuticals’ Operational Performance.NEWS2: Alexion’s Top Line Continues to Expand Significantly.NEWS3: Abbott Laboratories Is a 'Forever' Stock.NEWS4: Do Abiomed’s Valuations Look Attractive?.
2018-09-06: NEWS1: MS Global Franchise Fund Buys 1, Sells 4 in 2nd Quarter.NEWS2: 7 Lucrative Biotech Stocks With Up to 300% Upside.NEWS3: 7 Lucrative Biotech Stocks With Up to 300% Upside.NEWS4: What Alexion Pharmaceuticals’ Valuation Trend Indicates.NEWS5: Livongo Health expands under new offering with Abbott Labs.
2018-09-07: NEWS1: How Hologic’s Valuation Stacks Up with Peers.NEWS2: Top Research Reports for Abbott, Gilead & FedEx.NEWS3: Noteworthy ETF Inflows: XLV, MDT, ABT, BMY.NEWS4: Noteworthy ETF Inflows: XLV, MDT, ABT, BMY.
2018-09-10: NEWS1: Most Analysts Currently Call Boston Scientific a ‘Buy’.NEWS2: The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE.NEWS3: The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE.NEWS4: Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake.NEWS5: Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake.NEWS6: Abbott&apos;s DRG Therapy Now Covered by Aetna, To Boost Uptake.NEWS7: The Zacks Analyst Blog Highlights: Abbott, Gilead, FedEx, Archer Daniels and CBRE.

Answer: Rise